RespireRx Pharmaceuticals (RSPI) News Today → Prepare for a recession unlike any other (From American Hartford Gold Group) (Ad) Free RSPI Stock Alerts $0.0009 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRCKT Rocket Pharmaceuticals, Inc.seekingalpha.com - April 20 at 3:24 PMRespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injuryglobenewswire.com - March 20 at 8:30 AMRespireRx Pharmaceuticals shares Preclinical Pain Relief for their Non-Opioid Lead KRM-II-81proactiveinvestors.com - March 9 at 1:02 AMRespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directorsfinance.yahoo.com - January 22 at 4:39 PMRespireRx Pharmaceuticals Inc. Announces the Publication of a Case Report in which KRM-II-81 Totally Suppressed Epileptiform Activity in Brain Tissue Surgically Removed from Epileptic Patientfinance.yahoo.com - January 4 at 10:01 AMRespireRx Pharmaceuticals Inc. Announces Agreement with Ponto Ventures to Drive Business Development with Will Clodfelter as RespireRx Part-Time Senior VP of Business Developmentfinance.yahoo.com - December 11 at 10:13 AMRespireRx Pharmaceuticals subsidiary inks MSA for dronabinol manufacturingproactiveinvestors.com - October 12 at 4:01 PMRespireRx Pharmaceuticals Inc.’s Subsidiary ResolutionRx Ltd Enters into Master Services Agreement for Dronabinol Manufacturing and Related Servicesfinance.yahoo.com - October 12 at 9:28 AMPharmaceutical cannabis sales surge, clinical trials seeing broader disease focusproactiveinvestors.com - August 30 at 12:37 PMRespireRx Transferes Its Pharmaceutical Cannabinoid Program To ResolutionRxbenzinga.com - August 9 at 3:45 PMRespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Companyfinance.yahoo.com - August 9 at 10:44 AMAlnylam Pharmaceuticals (NASDAQ: ALNY)fool.com - June 24 at 7:36 AMRespireRx Pharmaceuticals' Australia cannabis subsidiary inks LOI securing $3.1M investmentproactiveinvestors.com - May 24 at 10:29 AMResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costsfinance.yahoo.com - May 24 at 10:29 AMRespireRx Pharmaceuticals Inc. (RSPI)finance.yahoo.com - May 16 at 8:58 AMRespireRx collaborates with University College London to study treatment options for GRIA disordersfinance.yahoo.com - April 21 at 11:02 AMRespireRx collaborating with University College London to study treatment options for GRIA disordersproactiveinvestors.com - April 20 at 1:30 PMRespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disordersfinance.yahoo.com - April 5 at 10:50 AMRespireRx Pharmaceuticals highlights analogs of its anti-seizure treatment in scientific publicationsproactiveinvestors.com - April 3 at 10:39 AMRespireRx Pharmaceuticals Inc. Discloses Novel Structural Analogs of its GABAA Receptor Potentiator, KRM-II-81 with Antiseizure Efficacy and Antitremor Effects without Sedation.finance.yahoo.com - April 3 at 10:39 AMRespireRx Pharmaceuticals appoints Joseph Siegelbaum as independent director on its boardproactiveinvestors.com - March 28 at 1:57 PMRespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directorsfinance.yahoo.com - March 28 at 8:56 AMRSPI RespireRx Pharmaceuticals Inc.seekingalpha.com - March 21 at 7:45 PMRespireRx Pharmaceuticals subsidiary ResolutionRX signs on iNGENu as CRO for dronabinol developmentproactiveinvestors.com - March 2 at 5:42 PMRespireRx Pharmaceuticals' Australian subsidiary ResolutionRx enters services agreement with CRO iNGENuproactiveinvestors.com - March 1 at 10:20 AMResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx’s Entry into a Services Agreement with iNGENu CRO Pty Ltdfinance.yahoo.com - March 1 at 10:20 AMResolutionRx announces research & development financing agreement with Radium Capitalproactiveinvestors.com - February 9 at 1:53 PMRespireRx Pharmaceuticals' Australian subsidiary inks loan agreements to advance R&D for sleep apnea treatmentproactiveinvestors.com - February 1 at 2:06 PMResolutionRx Ltd, a wholly owned subsidiary of RespireRx Pharmaceuticals Inc. Enters into LOI and Term Sheet with Radium Capital for the financing of anticipated Research and Development Creditsfinance.yahoo.com - February 1 at 2:06 PMRespireRx Pharmaceuticals strikes second amendment to its license agreement with the University of Illinoisproactiveinvestors.com - January 23 at 1:03 PMRespireRx Pharmaceuticals establishes ResolutionRx subsidiary in Australiaproactiveinvestors.com - January 23 at 1:03 PMRespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinoisfinance.yahoo.com - January 23 at 1:03 PMRespireRX Pharmaceuticals establishes ResolutionRX in Australia to advance its cannabinoid programproactiveinvestors.com - January 12 at 3:03 PMRespireRx sets up new Australian company to develop cannabinoid platformseekingalpha.com - January 12 at 3:03 PMRespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platformfinance.yahoo.com - January 12 at 3:03 PMRespireRx Pharmaceuticals joins NIH program to find non-opioid pain-relief mechanisms to combat addictionproactiveinvestors.com - December 5 at 6:03 PMRespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Developmentfinance.yahoo.com - December 5 at 6:03 PMRespireRx Pharmaceuticals shares new letter of intent with Australian companyproactiveinvestors.com - November 28 at 8:42 PMRespireRx Signs LOI With Australian CRO For Dronabinol Development For Obstructive Sleep Apneabenzinga.com - November 17 at 12:26 PMRespireRx Pharmaceuticals signs letter of intent with Australian CRO to study drug for treating obstructive sleep apneaproactiveinvestors.com - November 17 at 12:26 PMRespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apneafinance.yahoo.com - November 17 at 12:26 PMRespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company’s CFO is presenting at the Investor Summit Q4finance.yahoo.com - November 10 at 5:01 PMRespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summitfinance.yahoo.com - November 7 at 10:08 AMCANbridge Pharmaceuticals Data on CAN106 to be Presented at Two Conferencesfinance.yahoo.com - September 25 at 5:01 PMRespireRx Pharmaceuticals says its obstructive sleep apnea drug dronabinol featured in Sleep Review magazine free e-bookproactiveinvestors.com - August 8 at 3:36 PMRespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Editionfinance.yahoo.com - August 8 at 3:36 PMRespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa is an Invited Speaker at the 5th International Cannabinoid-Derived Pharmaceuticals Summitfinance.yahoo.com - May 24 at 11:48 AMProactive news headlines including Kontrol Technologies, Red Pine Exploration, RespireRx Pharmaceuticals, Kovo HealthTech and Jushi Holdingsapnews.com - May 17 at 3:51 PMRespireRx Pharmaceuticals Interim CEO talks AMPAkines in treating GRI disorders at virtual conferenceproactiveinvestors.com.au - May 17 at 3:51 PMRespireRx Pharmaceuticals Inc. Announces Recent RespireRx Presentation at 2022 GRI Virtual Conference presented by CureGRIN and GRIN Therapeutics.finance.yahoo.com - May 17 at 10:50 AM Get RespireRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RSPI and its competitors with MarketBeat's FREE daily newsletter. Email Address Prepare for a recession unlike any other (Ad)These 42 powerful nations just launched the first-ever “Anti-Dollar Alliance”… And together, they plan to KILL the greenback and DETHRONE America once and for all. Leading the charge are the usual suspects: Russia, China, Iran, oil-soaked Saudi Arabia, and even our neighbor, Mexico. And because this alliance holds close to 70% of all US Dollars… Ditching their holdings could flood America with a tsunami of US Dollars… Triggering hyper-inflation and a Wall Street nosedive so deep, it VAPORIZES trillions in hard-earned retirement savings. GET THE FREE GUIDE RSPI Media Mentions By Week RSPI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RSPI News Sentiment▼0.000.43▲Average Medical News Sentiment RSPI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RSPI Articles This Week▼10▲RSPI Articles Average Week Get RespireRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RSPI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ACUR News ADTX News BLPH News SXTC News ALLR News EVLO News CAPS News AMPE News EVFM News SPRC News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:RSPI) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceFed launches fourth dollar overhaulStansberry ResearchGreat Crypto BullWeiss RatingsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RespireRx Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
